Filter Results:
(561)
Show Results For
- All HBS Web
(561)
- People (4)
- News (144)
- Research (345)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(561)
- People (4)
- News (144)
- Research (345)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
presidential election as it unfolded in real-time, which was a highlight. In addition, we engaged with Dr. Amy Abernethy, Deputy Principal Commissioner of the FDA, and John Young, Chief Business Officer of Pfizer, to discuss the future of View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano... View Details
Richard M. Furlaud
Furlaud focused on Squibb's pharmaceuticals, investing in research and development that ultimately led to the introduction of several new drugs. Furlaud's streamlining and consistent support of the company's cardiovascular View Details
Keywords: Healthcare
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United... View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
more than 30 countries, Mumbai-based Piramal Group comprises companies focused on health care, life sciences, drug discovery, health care information management, financial services, specialty-glass packaging, and real estate. Recently,... View Details
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
For many decades, corporate research and development has been pretty much an "inside job." The road to innovative new products and services began and ended with a company's internal R&D. But according to HBS assistant... View Details
Keywords: by Jim Aisner
- 01 Jun 2018
- News
Floor It
leading from the street to the house itself. That insight, coupled with the radical nature of precision medicine, led to a realization: A “business as usual” approach wouldn’t do the trick; a different way of fighting cancer required an equally innovative approach to... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 25 Apr 2014
- News
Disrupting criminal enterprises that prey on children
Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
development of a course that could enhance decision making by providing participants with the knowledge and skills to better manage, fund, and commercialize scientific discoveries that could potentially cure illnesses ranging from... View Details
Keywords: Jennifer Gillespie
- Profile
Arjun Goyal
a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars... View Details
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
The blind man depicted in the sculpture suffers from river blindness, a disease that ravaged countless lives in the developing world until Merck researchers discovered the breakthrough drug Mectizan. The... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
programs to an investment board comprising both insiders (senior GSK executives) and outsiders (including a venture capitalist and a biotech CEO). After a three-month review period, successful teams are awarded three years worth of investment funding. Because View Details
Keywords: by Carmen Nobel
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
teachers to talk about AIDS prevention, the government can use a built-in educational infrastructure. Ngozi Edozien Ngozi Edozien, vice president of PPG Planning and Business Development for Pfizer, said the lack of a delivery... View Details
Keywords: by Julie Jette
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand... View Details
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
innovation and product development strategies. His latest research analyzes how open source norms of transparency, permeable access, and collaboration might work with scientists. What he and his coauthors discovered:... View Details
Keywords: by Martha Lagace